Corbus Pharmaceuticals Holdings, Inc. (CRBP) Earnings Calendar & Upcoming Events

Corbus Pharmaceuticals Holdings, Inc. (CRBP) — Price $7.26 HealthcareBiotechnology — NASDAQ

Latest reported results:

Corporate calendar for Corbus Pharmaceuticals Holdings, Inc. (CRBP): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid typ...

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-09-14
2026-09-14
2026-09-14
2026-09-14
2026-09-14$144M
2026-09-14$898M

Price

Price$7.26
Market Cap$135M
ExchangeNASDAQ
CountryUS

Related companies: ALEC · APLT · CRDF · ELTX · FBRX · IPHA · MIST

Explore sector: Healthcare · Biotechnology

More sections of CRBP: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks